Skip Nav Destination
Issues
15 December 1996
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Issue Sections
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Articles
Altered p16INK4 and Retinoblastoma Protein Status in Non-Small Cell Lung Cancer: Potential Synergistic Effect with Altered p53 Protein on Proliferative Activity
Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Takayuki Mishina; Kenji Akie; Motoi Nishi; Hiromitsu Hiroumi; Fumihiro Hommura; Yoshikazu Kawakami
Mutations in the Arginine-rich Protein Gene, in Lung, Breast, and Prostate Cancers, and in Squamous Cell Carcinoma of the Head and Neck1
Ravi Shridhar; Viji Shridhar; Sylvie Rivard; Jill M. Siegfried; Heline Pietraszkiewicz; John Ensley; Robert Pauley; David Grignon; Wael Sakr; Orlando J. Miller; David I. Smith
Identification of Novel Germline hMLH1 Mutations Including a 22 kb Alu-mediated Deletion in Patients with Familial Colorectal Cancer1
Jacques L. Mauillon; Pierre Michel; Jean-Marc Limacher; Jean-Baptiste Latouche; Pierre Dechelotte; Françoise Charbonnier; Cosette Martin; Viviane Moreau; Josette Metayer; Bernard Paillot; Thierry Frebourg
Transfection with Human Thioredoxin Increases Cell Proliferation and a Dominant-negative Mutant Thioredoxin Reverses the Transformed Phenotype of Human Breast Cancer Cells1
Alfred Gallegos; John R. Gasdaska; Charles W. Taylor; Gillian D. Paine-Murrieta; Daniel Goodman; Pamela Y. Gasdaska; Margareta Berggren; Margaret M. Briehl; Garth Powis
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.